A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge

A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy

(2019) Ellen M. Beer et al.   PLoS Neglected Tropical Diseases

Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments

(2018) Ryan S. Noyce et al.   PLoS One

Tecovirimat: First Global Approval

(2018) Sheridan M. Hoy   DRUGS

Oral Tecovirimat for the Treatment of Smallpox

(2018)   NEW ENGLAND JOURNAL OF MEDICINE

Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus

(2014) Scott Parker et al.   ANTIVIRAL RESEARCH

A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012

(2013) Scott Parker et al.   Future Virology

Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox – An animal model of smallpox

(2012) Scott Parker et al.   ANTIVIRAL RESEARCH

Progressive Vaccinia: Case Description and Laboratory-Guided Therapy With Vaccinia Immune Globulin, ST-246, and CMX001

(2012) E. R. Lederman et al.   JOURNAL OF INFECTIOUS DISEASES

Lethal Monkeypox Virus Infection of CAST/EiJ Mice Is Associated with a Deficient Gamma Interferon Response

(2012) P. L. Earl et al.   JOURNAL OF VIROLOGY

Passive Immunotherapies Protect WRvFire and IHD-J-Luc Vaccinia Virus-Infected Mice from Lethality by Reducing Viral Loads in the Upper Respiratory Tract and Internal Organs

(2011) M. Zaitseva et al.   JOURNAL OF VIROLOGY

Capturing the Natural Diversity of the Human Antibody Response against Vaccinia Virus

(2010) J. Lantto et al.   JOURNAL OF VIROLOGY

A Mouse Model of Lethal Infection for Evaluating Prophylactics and Therapeutics against Monkeypox Virus

(2010) J. Stabenow et al.   JOURNAL OF VIROLOGY

Identification of Wild-Derived Inbred Mouse Strains Highly Susceptible to Monkeypox Virus Infection for Use as Small Animal Models

(2010) J. L. Americo et al.   JOURNAL OF VIROLOGY

Poxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: Pathogenesis, prophylaxis, and antiviral therapy

(2010) Nanhai Chen et al.   VIROLOGY

Development of CMX001 for the Treatment of Poxvirus Infections

(2010) Randall Lanier et al.   Viruses-Basel

Therapeutic Vaccines and Antibodies for Treatment of Orthopoxvirus Infections

(2010) Yuhong Xiao et al.   Viruses-Basel

Ectromelia Virus Infections of Mice as a Model to Support the Licensure of Anti-Orthopoxvirus Therapeutics

(2010) Scott Parker et al.   Viruses-Basel

ST-246 Inhibits In Vivo Poxvirus Dissemination, Virus Shedding, and Systemic Disease Manifestation

(2009) A. Berhanu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The new ACAM2000™ vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks

(2009) Lauren Handley et al.   Expert Review of Vaccines

Efficacy of ST-246 versus lethal poxvirus challenge in immunodeficient mice

(2009) D. W. Grosenbach et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Single-Dose Safety and Pharmacokinetics of ST-246, a Novel Orthopoxvirus Egress Inhibitor

(2008) R. Jordan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Eczema vaccinatum resulting from the transmission of vaccinia virus from a smallpox vaccinee: An investigation of potential fomites in the home environment

(2008) Edith Lederman et al.   VACCINE

Mousepox in the C57BL/6 strain provides an improved model for evaluating anti-poxvirus therapies

(2008) Scott Parker et al.   VIROLOGY

Efficacy of therapeutic intervention with an oral ether–lipid analogue of cidofovir (CMX001) in a lethal mousepox model

(2007) Scott Parker et al.   ANTIVIRAL RESEARCH